70 Participants Needed

Arginine Toothpaste for Dry Mouth

AP
AB
Overseen ByAnn-Marie Billig
Age: 18+
Sex: Any
Trial Phase: Phase 3
Sponsor: Tufts University
Must be taking: Xerostomia medications
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Pivotal Trial (Near Approval)This treatment is in the last trial phase before FDA approval
Prior Safety DataThis treatment has passed at least one previous human trial

Trial Summary

What is the purpose of this trial?

This is a clinical investigation to measure the changes in the oral environment resulting from a 3 month exposure to an arginine containing toothpaste. This study is a double blind, randomized controlled, parallel design. Seventy (70) male and female subjects who meet the inclusion/exclusion criteria will be enrolled in the study. Following oral health evaluations, subjects will be assigned to the treatment schedule and receive their assigned study product.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, it requires participants to have been taking at least two medications that cause dry mouth for the last three months, so it seems you may continue with those medications.

What data supports the effectiveness of the treatment Arginine Toothpaste for Dry Mouth?

Research shows that toothpaste containing 1.5% arginine and fluoride is more effective at preventing cavities than regular fluoride toothpaste. Additionally, toothpaste with 8.0% arginine provides better relief for sensitive teeth compared to other sensitivity relief toothpastes.12345

Is arginine toothpaste safe for humans?

The research does not provide specific safety data for arginine toothpaste, but it is commonly used in products for sensitive teeth and has been studied for its effectiveness in reducing dentin hypersensitivity.12467

How does arginine toothpaste differ from other treatments for dry mouth?

Arginine toothpaste is unique because it contains 8.0% arginine and calcium carbonate, which are known for providing instant and lasting relief of dentin hypersensitivity, a condition related to dry mouth. This combination is different from other treatments that may not offer the same immediate and prolonged relief.12389

Research Team

AP

Athena Papas, DMD, PhD

Principal Investigator

Tufts University School of Dental Medicine

Eligibility Criteria

This trial is for men and women with dry mouth who meet specific health requirements. Participants will be using one of two toothpastes over three months to see if there's an improvement in their oral condition.

Inclusion Criteria

I am between 18 and 80 years old and in good health.
I rate my dryness severity at 4 or higher on a scale of 0 to 10.
I have been on two medications causing dry mouth for the last three months.
See 5 more

Exclusion Criteria

Subjects unable to understand or unwilling to sign the informed consent form
Participation in any other clinical study within 1 week prior to enrollment into this study
I am not taking new or higher doses of pilocarpine or similar medications.
See 12 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants use either a 1000 ppm F toothpaste or an 8% Arginine toothpaste for 12 weeks

12 weeks

Follow-up

Participants are monitored for changes in salivary pH and oral microbiome after treatment

4 weeks

Treatment Details

Interventions

  • Colgate Cavity Protection Fluoride Toothpaste
  • Tom's of Maine Rapid Relief toothpaste
Trial OverviewThe study compares Colgate Cavity Protection Fluoride Toothpaste with Tom's of Maine Rapid Relief toothpaste, both containing arginine, to see which is better for dry mouth over a period of three months.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Investigative Arm- Using an 8% Arginine toothpasteExperimental Treatment1 Intervention
For the study period (12 weeks), subjects in the Investigative Arm will be instructed to brush their teeth with an 8% Arginine toothpaste.
Group II: Control Arm- a 1000 ppm F toothpasteActive Control1 Intervention
For the study period (12 weeks), subjects in the Control Arm will be instructed to brush their teeth with Control Arm- a 1000 ppm F toothpaste.

Colgate Cavity Protection Fluoride Toothpaste is already approved in United States, India, European Union for the following indications:

🇺🇸
Approved in United States as Colgate Cavity Protection Fluoride Toothpaste for:
  • Prevention of dental caries
  • Relief of dentin hypersensitivity
🇮🇳
Approved in India as Colgate Strong Teeth Toothpaste for:
  • Prevention of dental caries
  • Relief of dentin hypersensitivity
  • Nourishment of teeth
🇪🇺
Approved in European Union as Colgate Cavity Protection Fluoride Toothpaste for:
  • Prevention of dental caries
  • Relief of dentin hypersensitivity

Find a Clinic Near You

Who Is Running the Clinical Trial?

Tufts University

Lead Sponsor

Trials
271
Recruited
595,000+

Colgate Palmolive

Industry Sponsor

Trials
106
Recruited
19,100+

Noel Wallace

Colgate Palmolive

Chief Executive Officer since 2019

MBA from Harvard Business School

Diana Haussling

Colgate Palmolive

Chief Marketing Officer since 2022

Bachelor's degree in Marketing

Findings from Research

A toothpaste containing 8.0% arginine and calcium carbonate (Pro-Argin technology) has been shown to provide superior immediate and lasting relief from dentin hypersensitivity compared to a strontium-based toothpaste.
Clinical studies indicate that the strontium-based toothpaste is not more effective than regular fluoride toothpaste for immediate sensitivity relief, highlighting the efficacy of the arginine-based formulation.
Advances in the clinical management of dentin hypersensitivity: a review of recent evidence for the efficacy of dentifrices in providing instant and lasting relief.Cummins, D.[2013]
The Colgate-Palmolive Company has conducted a clinical program to evaluate the benefits of adding 1.5% arginine to fluoride toothpaste.
This addition aims to enhance the effectiveness of fluoride in preventing dental issues, although specific results or outcomes from the clinical program are not detailed in the abstract.
Comment on the paper entitled 'Arginine and caries prevention: A systematic review'.[2018]
In an 8-week clinical study with 121 participants, a new Pro-Argin formula toothpaste significantly reduced dentin hypersensitivity compared to a negative control toothpaste, showing improvements in sensitivity to both tactile and air blast stimuli.
The new toothpaste's effectiveness was comparable to that of a commercial Pro-Argin formula toothpaste, indicating that it is a viable option for managing dentin hypersensitivity.
Dentin hypersensitivity reduction of a new toothpaste containing 8.0% arginine and 1450 ppm fluoride: an 8-week clinical study on Chinese adults.Que, K., Fu, Y., Lin, L., et al.[2013]

References

Advances in the clinical management of dentin hypersensitivity: a review of recent evidence for the efficacy of dentifrices in providing instant and lasting relief. [2013]
Comment on the paper entitled 'Arginine and caries prevention: A systematic review'. [2018]
Dentin hypersensitivity reduction of a new toothpaste containing 8.0% arginine and 1450 ppm fluoride: an 8-week clinical study on Chinese adults. [2013]
The new toothpastes. [2010]
The Superior Anti-caries Efficacy of Fluoride Toothpaste Containing 1.5% Arginine. [2018]
Randomized in situ clinical study comparing the ability of two new desensitizing toothpaste technologies to occlude patent dentin tubules. [2022]
The use of the Modified Gingival Margin Plaque Index (MGMPI) method to investigate the inhibitory effect of various toothpastes on dental plaque formation. [2013]
Arginine-containing toothpastes for dentin hypersensitivity: systematic review and meta-analysis. [2021]
Clinical evidence for the superior efficacy of a dentifrice containing 8.0% arginine and calcium carbonate in providing instant and lasting relief of dentin hypersensitivity. [2014]